UnitedHealth Group stock steadies as earnings and cyberattack fallout reshape outlook

UnitedHealth Group's stock remains stable as investors assess strong earnings against persistent costs from the Change Healthcare cyberattack and increased regulatory scrutiny of its Optum unit. Despite cyberattack-related expenses, the company reported consolidated revenue exceeding $100 billion in the recent quarter and maintained positive EPS growth. UnitedHealth Group reaffirmed its full-year revenue and adjusted EPS guidance, emphasizing its diversified business model, capital returns, and strategic focus on value-based care and technology investments, even as regulatory bodies intensify their oversight of its market position.